Solventum Corporation (SOLV) Stock Price & Analysis
Solventum Corporation (SOLV) closed at USD 87.45 on Thursday, October 22, 2026, up 0.90% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 87.45; the Oct 22, 2026 session ranged USD 86.42–87.87 on volume of 769,723 shares. Market capitalization is —, with a 52-week range of USD 62.38–94.16 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 09:26 UTC.
Also available as compact Markdown for AI agents: nexqual.com/SOLV.md
Key facts (SOLV)
- Last four reported quarters (through Jun 30, 2026): revenue $8.31B, net income $1.43B (17.3% margin), free cash flow -$118M (SEC filings).
- 4 of 80 tracked superinvestors hold SOLV (13F, Q2 2026): 0 new, 0 added, 3 reduced, 1 unchanged.
- Analysts: Hold (mean 2.60 on a 1–5 scale) (15 analysts), mean target USD 94.69 (range 71–113).
- Total return with dividends: 1Y +21.0% vs S&P 500 +14.9%; 5Y +25.7% vs S&P 500 +80.3%.
- Next earnings: 2026-11-05, EPS estimate USD 1.34, revenue estimate $1.93B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (SOLV)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $8.13B | $8.20B | $8.25B | $8.32B | $8.31B |
| Gross profit | $4.70B | $4.69B | $4.59B | $4.45B | — |
| Operating income | $1.69B | $1.69B | $1.04B | $2.18B | $2.08B |
| Net income | $1.34B | $1.35B | $479M | $1.56B | $1.43B |
| EPS (diluted) | $7.78 | $7.79 | $2.76 | $8.88 | — |
| Free cash flow | $1.43B | $1.63B | $805M | -$10.0M | -$118M |
| Gross margin | 57.7% | 57.3% | 55.6% | 53.5% | — |
| Operating margin | 20.8% | 20.6% | 12.6% | 26.2% | 25.0% |
| Net margin | 16.5% | 16.4% | 5.8% | 18.7% | 17.3% |
| Revenue growth | — | +0.8% | +0.7% | +0.9% | — |
| Cash + short-term investments | $61.0M | $194M | $762M | $878M | — |
| Total debt | — | $0K | $8.01B | $5.04B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (SOLV)
P/E at fiscal year-ends: Dec 2025 8.9x, Dec 2024 24.0x.
Superinvestors (SEC 13F-HR, Q2 2026) (SOLV)
4 of 80 tracked investors hold SOLV. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Nelson Peltz | Trian Fund Management | 15.02% | $635M | Unchanged |
| Christopher Davis | Davis Advisors | 2.09% | $487M | Reduced -0.4% |
| Richard Pzena | Pzena Investment Management | 0.09% | $32.2M | Reduced -5.0% |
| Mairs & Power | Mairs & Power Funds | 0.05% | $5.6M | Reduced -0.1% |
Analysts (SOLV)
Consensus Hold (mean 2.60 on a 1–5 scale), 15 analysts; mean target USD 94.69 (low 71, high 113).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-14 | BTIG | Reiterated | Buy | $95 |
| 2026-08-06 | UBS | Target raised | Buy | $95 → $101 |
| 2026-08-06 | Piper Sandler | Target raised | Overweight | $92 → $105 |
| 2026-08-06 | Wedbush | Target raised | Outperform | $94 → $101 |
| 2026-08-06 | Keybanc | Target raised | Overweight | $93 → $102 |
| 2026-08-06 | Stifel | Target raised | Buy | $90 → $100 |
| 2026-08-06 | BTIG | Target raised | Buy | $91 → $95 |
| 2026-07-28 | UBS | Upgrade | Neutral → Buy | $95 |
| 2026-07-09 | BMO Capital | Initiated | Market Perform | $81 |
Total return (dividends reinvested) (SOLV)
| 1Y (from 2025-10-23) | 5Y (from 2024-03-25) | |
|---|---|---|
| Total return | +21.0% | +25.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +21.1% | +9.3% |
| Volatility (annualized) | 29.7% | 29.4% |
| Max drawdown | -27.5% (Jan 2026→Apr 2026) | -30.1% (Apr 2024→Jul 2024) |
Companies that name SOLV in their SEC reports
| Relationship to SOLV | Company | Filing | Sentence |
|---|---|---|---|
| customer | 3M CO (MMM) | 10-K Feb 3, 2026 | “In connection with the separation, the Company and Solventum entered into various agreements that provide for the performance of certain services or provision of goods by each company for the benefit of the other, including a separation and distribution agreement, a transition services agreement, a tax matters agreement, an employee matters agreement, a transition distribution services agreement, a transition cont…” |
SOLV analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $1.34 | $1.41 | -4.8% | $1.93B | 11 |
| Next quarter (ends Dec 2026) | $1.79 | $1.78 | +0.5% | $2.09B | 11 |
| Current fiscal year (ends Dec 2026) | $7.14 | $6.55 | +9.0% | $8.23B | 15 |
| Next fiscal year (ends Dec 2027) | $7.25 | $7.09 | +2.3% | $8.52B | 15 |
SOLV options: expected move
Options price a move of about ±8.8% (±$7.75) by Nov 20, 2026, which includes earnings on Nov 5, 2026.
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 37.7% | ±8.8% |
| Dec 18, 2026 | 56 | 34.4% | ±11.1% |
| Jan 15, 2027 | 84 | 31.4% | ±12.4% |
| Apr 16, 2027 | 175 | 30.1% | ±16.9% |
30-day implied volatility 36.2% vs 18.5% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 09:26 UTC)
| Price | USD 87.45 |
|---|---|
| Change | ▲ 0.90% (up) |
| Previous Close | USD 87.45 |
| Open | USD 87.45 |
| Day Range | USD 86.42 – 87.87 |
| 52-Week Range | USD 62.38 – 94.16 |
| Volume | 769,723 shares |
| Market Cap | — |
| Exchange | NYQ |
Technical Analysis (SOLV)
Nexqual's technical model rates SOLV "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of October 23, 2026 at 09:26 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.56 (neutral) |
| vs SMA50 | Below (USD 88.59) |
| MACD | -0.49 (negative) |
Analyst Ratings (SOLV)
Wall Street analysts rate SOLV "Hold" based on 15 analysts, with a mean price target of USD 94.69 (range USD 71–113), per Nexqual as of October 23, 2026 at 09:26 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 15 |
| Mean Target | USD 94.69 |
| High Target | USD 113 |
| Low Target | USD 71 |
| Buy / Hold / Sell | 8 / 5 / 2 |
Earnings (SOLV)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD 1.34 |
| Revenue Estimate | $1.93B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD 2.55 vs est 1.91 ▲ beat |
| 2026-03-31 | USD 1.48 vs est 1.35 ▲ beat |
| 2025-12-31 | USD 1.57 vs est 1.5 ▲ beat |
| 2025-09-30 | USD 1.5 vs est 1.43 ▲ beat |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financials & Fundamentals (SOLV)
| Total Revenue | $8.31B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +2.20% |
| Gross Margin | +54.78% |
| Operating Margin | +9.78% |
| Profit Margin | +17.26% |
| ROE | +33.96% |
| Debt / Equity | 1.1 |
| Current Ratio | 1.02 |
| Total Cash | $403.00M |
| Total Debt | $5.30B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$118.00M (-1.4% of revenue) |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Financial Health Score (SOLV)
Nexqual rates Solventum Corporation's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 09:26 UTC.
| Growth | Mixed — Revenue +0.9% YoY (annual), slow |
|---|---|
| Profitability | Strong — Gross margin 55%, operating 10% (last 12 months) |
| Balance Sheet | Mixed — $403M cash and investments vs $5.08B debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$118M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Strong — ROE 34%, ROA 2.7% |
Ownership (SOLV)
| Insider Ownership | +15.34% |
|---|---|
| Institutional Ownership | +75.96% |
| Shares Outstanding | 170.22M |
| Float | 144.09M |
| Short % of Float | +3.39% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Leadership (SOLV)
Solventum Corporation is led by Bryan C. Hanson, CEO & Director, per Nexqual as of October 23, 2026 at 09:26 UTC.
| CEO & Director | Bryan C. Hanson |
|---|---|
| Executive VP & CFO | Wayde D. McMillan |
| Senior Vice President of Investor Relations & External Finance Communications | Amy Wakeham |
| Chief Strategy & Corporate Development Officer | Rachel H. Ellingson |
Major Backers & Investors (SOLV)
Notable institutional backers of Solventum Corporation include Independent Franchise Partners, LLP, Trian Fund Management, LP, Davis Selected Advisers, according to Nexqual as of October 23, 2026 at 09:26 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Independent Franchise Partners, LLP | 9.5% |
| Trian Fund Management, LP | 4.84% |
| Davis Selected Advisers | 3.71% |
| Boston Partners | 2.37% |
| Invesco | 1.94% |
| John Hancock Funds III-Disciplined Value Mid Cap Fund | 1.4% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 9.37% |
| BlackRock | 5.73% |
| State Street | 3.31% |
| Geode Capital | 2.88% |
Source: Nexqual, October 23, 2026 at 09:26 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BAX | Baxter International Inc. | USD 25.65 | ▲ 3.85% |
| COO | The Cooper Companies, Inc. | USD 61.65 | ▲ 4.54% |
| AVTR | Avantor, Inc. | USD 17.15 | ▼ 0.64% |
| RGEN | Repligen Corporation | USD 178.71 | ▼ 0.72% |
| ALGN | Align Technology, Inc. | USD 155.51 | ▲ 2.74% |
| ATR | AptarGroup, Inc. | USD 128.1 | ▲ 1.97% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 09:26 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt